Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.
Visit our Writing Guide or this topic page for additional help.
Timeline
June 23, 2021
Glycomine raises a $68,000,000 series B round.
August 7, 2019
Glycomine raises a $33,000,000 series B round from Novo Holdings A/S.
August 2019
Glycomine raises a $33,000,000 series B round from Novo Holdings A/S.
November 16, 2017
Glycomine raises a $12,000,000 series A round from Sanderling Ventures.
Funding Rounds
Patents
Further Resources
Title
Author
Link
Type
Date
News
Title
Author
Date
Publisher
Description
FinSMEs
June 25, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
References
Organization
CompanyCompany attributes
Biomedical engineering
Biotechnology
Biopharmaceutical
EngineeringLocation
San Carlos, CaliforniaCompany Operating Status
Active
Pitchbook URL
Number of Employees (Ranges)
5 – 9
Full Address
733 Industrial Road San Carlos, CA 94070
Asahi Kasei
Novo Holdings A/S
Sanderling Ventures
Mesa Verde Venture Partners
Sanofi GenzymeEmail Address
info@glycomine.com
Phone Number
+16502647560
Total Funding Amount (USD)
146,000,000
Latest Funding Round Date
June 23, 2021
Former CEO
Peter McWilliamsLatest Funding Type
Series B roundPatents Assigned (Count)
1
United StatesCategories
Related Topics
Contributors
- 1
Bezmenov Serhii
I am studying cryptocurrency. I live in Ukraine. I work as a sales manager. I like to study and benefit projects in the crypto industry. - 2
Umair Shah
I am Word Press expert website designing is my passion. I love to learn new things - 3
Erin Scherfner
loading information... - 4
Seotaek Lee
interested in web3 - 5
Duzenko Andrey
Extensive experience in development and interaction with the community - 6
Katrina-Kay Pettitt
Data Duchess @ Golden
